Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 10/31/2024CDE Issues the List of Reference Formulations for GQCE Studies (84th B...
  • 10/30/2024China Set to Achieve Full Drug and Medical Consumables Traceability by...
  • 10/30/2024Zai Lab and BMS Move Toward KarXT Filing in China After Positive Phase...
  • 10/30/2024AstraZeneca China President Under Investigation Amid Broader Scrutiny ...
  • 10/30/2024Innovent Announces Positive Phase 2 Results for Picankibart in Psorias...
  • 10/30/2024China's BMI Negotiation Spotlight Record Number of Orphan Drugs
  • 10/30/2024Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong
  • 10/29/2024Innovative Drugs Lead the 2024 Health Insurance Price Negotiations in ...
  • 10/29/2024Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...
  • 10/29/2024GSK Acquires CMG1A46 from Chimagen Biosciences to Expand Immunology P...
  • 10/29/2024Nine Pharma MNCs Grew Their Combined China Revenue at 12.5% CAGR betwe...
  • 10/29/2024SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024 (with Annual M...
  • 10/29/2024CDE Issues the Common Issues and Technical Requirements for Replicatio...
  • 10/28/2024China Begins 2024 NRDL Negotiations with Key Focus on Innovation and P...
  • 10/28/2024China Expands Contract Manufacturing for Biopharmaceuticals in New Pil...
  • 10/28/2024NiKang Presents Discovery of NKT3964, a FIC, Highly Potent and Selecti...
  • 10/28/2024Baxter Halts Intravenous Therapy Operations in China Amid Market Chall...
  • 10/28/2024BeiGene Executive Under Investigation in China Amid Scrutiny of AstraZ...
  • 10/28/2024Cytoship Secures Angel Funding to Advance Cutting-Edge Delivery Vector...
  • 10/28/2024USFDA Clears RiboX's IND for Circular RNA Therapy RXRG001
  • 10/28/2024Innovent's Subsidiary Fortvita Secures Strategic Investment in $20.5M ...
  • 10/28/2024CSPC's BCMA-targeted mRNA-LNP-Based CAR-T SYS6020 Secures New Clinical...
  • 10/28/2024CORXEL and LENZ Therapeutics Announce Positive Topline Data from China...
  • 10/28/2024Beihai Biotech's BEIZRAY® (BH009) Receives FDA Approval for Multiple ...
  • 10/28/2024Akeso's Gumokimab Shows Exceptional Long-Term Efficacy in Phase 3 Psor...
  • 10/25/2024Recent Executive Moves
  • 10/25/2024China Expands Free HPV Vaccination to Reach 40% of Eligible Girls
  • 10/25/2024China Succeeds in Reducing Premature Death from Chronic Diseases
  • 10/25/2024CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
  • 10/25/2024Data Review: Chinese Drug Market 2016-2023
  • Page:13/42 Total number of articles:1234: [First][<<] [11] [12] [13] [14] [15] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group